PHAXIAM Therapeutics (PHXM) News Today → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free PHXM Stock Alerts $3.10 -0.02 (-0.64%) (As of 03/8/2024) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePhaxiam enrols first patient in endocarditis infection studymsn.com - April 15 at 11:42 PMPHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureusglobenewswire.com - April 15 at 1:30 AMPhaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)finanznachrichten.de - April 5 at 2:14 PMPHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)globenewswire.com - April 5 at 12:00 PMONCT Oncternal Therapeutics, Inc.seekingalpha.com - March 23 at 3:52 PMPHAXIAM Announces 2023 Full-Year Results and Provides Business Updateglobenewswire.com - March 20 at 1:00 PMPhaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Marketfinanznachrichten.de - March 11 at 3:42 AMPhaxiam Therapeutics Says Delisting Of ADSs From Nasdaq Effectivemarkets.businessinsider.com - March 11 at 3:42 AMPHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Marketglobenewswire.com - March 11 at 2:00 AMMonthly information related to total number of voting rights and shares composing the share capital - February 29, 2024finance.yahoo.com - March 5 at 2:37 PMmarketbeat.com - February 21 at 9:32 AMmarketbeat.com - February 20 at 4:18 PMPHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Marketglobenewswire.com - February 20 at 4:05 PMMonthly information related to total number of voting rights and shares composing the share capital - January 31, 2024finance.yahoo.com - February 7 at 1:23 PMPhaxiam Therapeutics S.A.: PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024finanznachrichten.de - January 19 at 10:48 AMPHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024finance.yahoo.com - January 18 at 5:56 PMMonthly information related to total number of voting rights and shares composing the share capital - December 31, 2023finance.yahoo.com - January 3 at 6:18 PMMonthly information related to total number of voting rights and shares composing the share capital - November 30, 2023finance.yahoo.com - December 6 at 7:23 PMPhaxiam Therapeutics Share Price (PHXM.PA)lse.co.uk - November 28 at 11:52 PMPhaxiam Therapeutics S.A.: PHAXIAM Provides Business and Financial Update for the Third Quarter of 2023finanznachrichten.de - November 15 at 10:25 AMPHAXIAM Therapeutics SA ADR PHXMmorningstar.com - November 14 at 11:32 PMPHAXIAM Provides Business and Financial Update for the Third Quarter of 2023finance.yahoo.com - November 14 at 6:32 PMmarketbeat.com - November 14 at 10:21 AMPHAXIAM Therapeutics SA ADRmorningstar.com - November 11 at 7:59 PMMonthly information related to total number of voting rights and shares composing the share capital _ October 31, 2023finance.yahoo.com - November 7 at 2:56 PMPhaxiam Therapeutics SA DRC (PHXM)investing.com - October 29 at 4:51 PMPHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureusfinance.yahoo.com - October 24 at 8:10 PMPhaxiam Therapeutics S.A.: TP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a "Buy" recommendationfinanznachrichten.de - October 23 at 6:08 PMTP ICAP Midcap initiates coverage of PHAXIAM Therapeutics with a “Buy” recommendationfinance.yahoo.com - October 23 at 6:08 PMMonthly information related to total number of voting rights and shares composing the share capital _September 30, 2023finance.yahoo.com - October 23 at 1:08 PMPHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strainsmarkets.businessinsider.com - October 9 at 8:30 PMPHAXIAM Receives Compliance Notice from Nasdaqfinance.yahoo.com - October 4 at 7:52 PMPhaxiam Therapeutics S.A.: PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaborationfinanznachrichten.de - October 3 at 6:27 PMPHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaborationfinance.yahoo.com - October 3 at 6:27 PMPHAXIAM Therapeutics SA (PHXM)investing.com - September 22 at 11:34 PMPHAXIAM Provides Business and Financial Update For the First Half of 2023markets.businessinsider.com - September 22 at 8:28 AMPHAXIAM Therapeutics S.A. (PHXM)finance.yahoo.com - September 21 at 9:39 AMmarketbeat.com - September 19 at 9:56 AMmarketbeat.com - September 19 at 9:36 AMPHAXIAM Therapeutics announces the completion of its reverse share splitfinance.yahoo.com - September 18 at 8:10 AMPHAXIAM Therapeutics Stock (NASDAQ:PHXM), Earnings Estimates, EPS, and Revenuebenzinga.com - September 11 at 10:36 PMPHAXIAM Therapeutics publishes its cash position and new financial calendar, and announces its participation at upcoming investor conferencesfinance.yahoo.com - September 5 at 10:07 PMWhy Is PHAXIAM Therapeutics (PHXM) Stock Up 37% Today?investorplace.com - August 10 at 9:15 AM Get PHAXIAM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PHXM and its competitors with MarketBeat's FREE daily newsletter. Email Address His win rate puts Warren Buffett to shame… (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss. Click here now for the full story. PHXM Media Mentions By Week PHXM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHXM News Sentiment▼0.000.34▲Average Medical News Sentiment PHXM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHXM Articles This Week▼01▲PHXM Articles Average Week Get PHAXIAM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PHXM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Monopar Therapeutics News Today Purple Biotech News Today Plus Therapeutics News Today Vaccinex News Today PaxMedica News Today Vincerx Pharma News Today Fresh Tracks Therapeutics News Today Exicure News Today SeaStar Medical News Today LianBio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHXM) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryHas Jeff Bezos Found the Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PHAXIAM Therapeutics S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
